NCT07904910: Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study.
- State
- Under way
- Phase
- Phase 3
- People
- 35 planned
- Started
- 15 May 2026
- Primary completion
- 15 Nov 2026
- Arms
- Crisaborole 2% ointment combined with Excimer light therapy
- Results
- None posted
- 15 May 2026: Trial started
- 29 Oct 2026: Trial registered